Environmental toxicants like lead, mercury target stem cells

Low levels of toxic substances cause critical stem cells in the central nervous system to prematurely shut down. That is the conclusion of a study published today in the on-line journal PLoS Biology. This research, which is the first to identify a common molecular trigger for the effects of toxicant exposure, may give scientists new insights into damage caused by toxicant exposure and new methods of evaluating the safety of chemicals.

While scientists have long understood that certain chemicals like lead and mercury have adverse effects on the body, the precise molecular mechanism by which many of these substances cause harm remain uncertain. This makes it more difficult to concretely link individual toxic substances with specific diseases or determine – with greater confidence – whether or not a chemical is toxic. However, recent advances in molecular biology, genetics, and stem cell biology have provided scientists a new window onto the impact of toxic substances on the cellular and molecular level.

"Establishing the general principles underlying the effects of toxicant exposure on the body is one of the central challenges of toxicology research," said University of Rochester biomedical geneticist Mark Noble, Ph.D., senior author of the study. "We have discovered a previously unrecognized regulatory pathway on which chemically diverse toxicants converge and disrupt normal cell function."

Noble and his colleagues exposed a specific population of brain cells to low levels of lead, mercury, and paraquat, one of the most widely used herbicides in the world. These cells, called glial progenitors, are advanced-stage stem cells that are critical to the growth, development, and normal function of the central nervous system. The activity of cells is regulated by molecular pathways – or controlled chemical reactions – normally set off when substances bind to receptors on the cell's surface. Noble and his colleagues found that these compounds turned off specific sets of receptors and set into motion a molecular chain reaction that causes the cells to shut down and stop dividing.

"These toxicants are activating a normal cellular regulatory pathway, they are just activating it inappropriately," said Noble. "If this disruption occurs during critical developmental periods, like fetal growth or early childhood, it can have a significant impact. Development is a cumulative process, and the effects of even small changes in progenitor cell division and differentiation over multiple generations could have a substantial effect on an organism."

This study is an example of the ability of stem cell research to shed new light on many diseases and health problems that have heretofore been poorly understood by the medical community. Noble and his colleagues are pioneers in the field and have been involved in the discovery of several of the progenitor cells that are involved in building the central nervous system. The growing knowledge of the precise timing and role of these cells has enabled scientists to explore the molecular origin of these diseases, and the Rochester team's findings are part of a growing number of discoveries that indicate that certain developmental syndromes may be the result of disruption in stem cell function.

There are tens of thousands of synthetic industrial chemicals, pesticides, metals, and other substances for which toxicological information is limited or nonexistent. By identifying a molecular target that is shared by toxic substances, all with very different chemical compositions, this discovery may give scientists a method to rapidly evaluate compounds to determine whether or not they pose a potential health threat.

"One of the obstacles in the analysis of new chemicals is the difficulty in developing a system that is sensitive enough and can make predictions that are true for both individual cells and the entire organism," said Noble. "This novel pathway gives as a way to analyze a diverse array of chemicals at levels in which they would be encountered in the environment. Furthermore, by identifying a specific molecular pathway that is activated by toxic exposure, we can now begin to look at specific ways to protect cells from this disruption of signaling."

Source: University of Rochester Medical Center

Related stories:

Century-old rule of chemistry overturned -- major implications for drug delivery
A new study by research chemists at the University of Warwick has challenged a century old rule of pharmacology that defined how quickly key chemicals can pass across cell walls. The new observations of the Warwick researchers suggest that the real transport rates could be up to a hundred times slower than predicted by the century old "Overton's Rule". This could have major implications for the development and testing of many future drugs.
Study on salmonella self-destruction
ETH Zurich biologists, led by Professors Martin Ackermann and Wolf-Dietrich Hardt, in collaboration with Michael Doebeli of the University of British Colombia in Vancouver (CN), have been able to describe how random molecular processes during cell division allow some cells to engage in a self-destructive act to generate a greater common good, thereby improving the situation of the surviving siblings.
New method to overcome multiple drug resistant diseases developed by Stanford researchers
Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them.
Pouring oil on troubled waters – scientists solve secrets of the water-oil interface
(PhysOrg.com) -- When oil and water are poured together they meet each other head-on to form a strong and rigid boundary between each other, says new research into how interactions between oil and water work, out this week in Physical Review Letters.
Pre-eclampsia may be autoimmune disease
Biochemists at The University of Texas Medical School at Houston say they are the first to provide pre-clinical evidence that pregnancy-induced high blood pressure or pre-eclampsia may be an autoimmune disease. Their research could provide novel diagnostic and therapeutic possibilities for this intractable disease. Findings appear online in Nature Medicine on July 27.
Argyrin: Natural substance raises hope for new cancer therapies
The effective treatment of many forms of cancer continues to pose a major problem for medicine. Many tumours fail to respond to standard forms of chemotherapy or become resistant to the medication. Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, the Hannover Medical School (MHH) and Leibniz-Universität (LUH) in Hanover have now discovered a chemical mechanism with which a natural substance - argyrin - destroys tumours. Today, the researchers publish their findings in the renowned scientific journal Cancer Cell.
Fortified cassava could provide a day's nutrition in a single meal
Scientists have determined how to fortify the cassava plant, a staple root crop in many developing countries, with enough vitamins, minerals and protein to provide the poor and malnourished with a day's worth of nutrition in a single meal.
Scientists discover how an injured embryo can regenerate itself
Keep its organs in relative proportion
More than 80 years have passed since the German scientist Hans Spemann conducted his famous experiment that laid the foundations for the field of embryonic development. After dividing a salamander embryo in half, Spemann noticed that one half – specifically, the half that gives rise to the salamander's 'belly' (ventral) starts to wither away. However, the other 'back' (dorsal) half that develops into its head, brain and spinal cord, continues to grow, regenerating the missing belly half and develops into a complete, though be it smaller, fully functional embryo. Spemann then conducted another experiment, where this time, he removed a few cells from the back half of one embryo and transplanted them into the belly half of a different embryo. To his surprise, this gave rise to a Siamese twin embryo where an extra head was generated from the transplanted cells. Moreover, although the resulting embryo was smaller than normal, all its tissues and organs developed in the right proportions irrespective of its size, and functioned properly. For this work, Spemann received the Nobel Prize in Physiology or Medicine in 1935.

News discussion:

General Science news